Shares of EndoChoice Holdings Inc. (NYSE:GI) saw an uptick in trading volume on Friday . 147,856 shares were traded during trading, an increase of 92% from the previous session’s volume of 76,880 shares.The stock last traded at $4.03 and had previously closed at $4.13.

GI has been the topic of several recent research reports. Zacks Investment Research cut EndoChoice Holdings from a “hold” rating to a “sell” rating in a report on Tuesday, May 3rd. Stifel Nicolaus decreased their price target on EndoChoice Holdings from $10.00 to $7.00 and set a “buy” rating on the stock in a report on Thursday. JPMorgan Chase & Co. initiated coverage on EndoChoice Holdings in a report on Wednesday, July 13th. They issued an “overweight” rating on the stock. Finally, William Blair cut EndoChoice Holdings from an “outperform” rating to a “market perform” rating in a report on Thursday. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $7.42.

The company’s market cap is $104.04 million. The firm’s 50-day moving average is $4.90 and its 200-day moving average is $4.93.

EndoChoice Holdings (NYSE:GI) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported ($0.99) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.52) by $0.47. The business earned $19.30 million during the quarter, compared to analysts’ expectations of $20.67 million. EndoChoice Holdings’s quarterly revenue was up 3.8% on a year-over-year basis. During the same period in the previous year, the company earned ($1.01) earnings per share. On average, equities research analysts expect that EndoChoice Holdings Inc. will post ($2.18) EPS for the current fiscal year.

A hedge fund recently raised its stake in EndoChoice Holdings stock. Bank of Montreal Can raised its position in EndoChoice Holdings Inc. (NYSE:GI) by 25.5% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 566,845 shares of the company’s stock after buying an additional 115,260 shares during the period. Bank of Montreal Can owned about 2.29% of EndoChoice Holdings worth $4,733,000 as of its most recent filing with the SEC.

Endochoice Holdings, Inc, formerly ECPM Holdings, LLC, is a medical device company. The Company is focused on designing and commercializing a platform of products for gastrointestinal (GI) caregivers. It offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.